Expression of Shelterin Component <i>POT1</i> Is Associated with Decreased Telomere Length and Immunity Condition in Humans with Severe Aplastic Anemia

<table>Postulated pathogenesis of aplastic anemia.</table>

Journal of Immunology Research

fig9

Figure 9

Figure 9: Expression of Shelterin Component <i>POT1</i> Is Associated with Decreased Telomere Length and Immunity Condition in Humans with Severe Aplastic Anemia 

Figure 9 | Expression of Shelterin Component POT1 Is Associated with Decreased Telomere Length and Immunity Condition in Humans with Severe Aplastic Anemia 